Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of interpretable machine learning models to predict 30-day mortality in patients with intracerebral hemorrhage.

Scientific reports·2026
Same author

Autologous concentrated growth factors promote M2 macrophage polarization to accelerate wound healing after anal fistula surgery by activating the AKT/mTOR pathway.

BMC gastroenterology·2026
Same author

The role of digital pharmaceutical governance in alleviating health inequality: a case study of the "Sanya Model" for centralized regional prescription review.

Frontiers in public health·2026
Same author

Partial reconstitution of the prophenoloxidase activation system in <i>Anopheles gambiae</i>.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Immunometabolic mechanisms of osteosarcopenic obesity: chronic inflammation, trained immunity, and systemic immune dysregulation.

Frontiers in immunology·2026
Same author

Dipeptidyl peptidase IV processing activates Manduca sexta pro-moricin-6: structural basis of enhanced antimicrobial activity.

Insect biochemistry and molecular biology·2026

Related Experiment Video

Updated: Feb 27, 2026

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System
08:57

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System

Published on: July 17, 2021

8.4K

Improving the baculovirus expression vector system with vankyrin-enhanced technology.

Kendra H Steele1, Barbara J Stone1, Kathleen M Franklin1

  • 1ParaTechs Corporation, Lexington, KY.

Biotechnology Progress
|June 27, 2017
PubMed
Summary

This study enhances the baculovirus expression vector system (BEVS) by using vankyrin to delay insect cell death and increase recombinant protein production, including complex glycoproteins.

Keywords:
SfSWTbaculovirusdifficult to express proteinsglycosylationvankyrin

More Related Videos

Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells
09:14

Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells

Published on: August 20, 2018

12.3K
Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

16.0K

Related Experiment Videos

Last Updated: Feb 27, 2026

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System
08:57

Production of Recombinant PRMT Proteins using the Baculovirus Expression Vector System

Published on: July 17, 2021

8.4K
Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells
09:14

Modifying Baculovirus Expression Vectors to Produce Secreted Plant Proteins in Insect Cells

Published on: August 20, 2018

12.3K
Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

16.0K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Biochemistry

Background:

  • The baculovirus expression vector system (BEVS) is a common method for producing recombinant proteins.
  • BEVS faces limitations, including the inability of insect cells to produce complex N-glycosylated proteins and reduced yields due to cell lysis post-infection.

Purpose of the Study:

  • To overcome BEVS limitations by delaying insect cell death and enhancing recombinant glycoprotein production.
  • To investigate the efficacy of vankyrin, an anti-apoptotic protein, in improving protein yields and glycosylation patterns.

Main Methods:

  • Insect cell lines (Sf9, High Five™, SfSWT-4) were transformed with a vankyrin gene (P-vank-1).
  • Baculovirus vectors were modified to express vankyrin.
  • Vankyrin-expressing cells were infected with vankyrin-encoding baculoviruses to assess protein yield and glycosylation.

Main Results:

  • Vankyrin expression delayed cell lysis and increased recombinant glycoprotein yield in SfSWT-4 cells.
  • A synergistic effect was observed with vankyrin-expressing cells combined with vankyrin-encoding baculovirus.
  • These improvements were demonstrated with various model proteins, including therapeutic proteins.

Conclusions:

  • Constitutive expression of vankyrin in insect cells or use of vankyrin-encoding baculovirus vectors effectively delays cell lysis.
  • These strategies significantly increase recombinant protein yields, addressing key limitations of the BEVS.